NLNerea Lago-Baameiro

Nerea Lago-Baameiro

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nerea Lago-Baameiro has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • María Pardo

    CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Av Monforte de Lemos 3-5, 28029 Madrid, Spain; Grupo Obesidómica, Área de Endocrinología, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complexo Hospitalario Universitario de Santiago de Compostela/SERGAS, Travesía da Choupana s/n, 15706 Santiago de Compostela, A Coruña, Spain

    3 shared publications
  • Antonio Piñeiro-Ces

    Department of Ophthalmology, University Hospital of Santiago de Compostela, Ramon Baltar S/N, 15706 Santiago de Compostela, Spain

    2 shared publications
  • Manuel F. Bande

    Department of Ophthalmology, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain

    2 shared publications
  • Paula Silva-Rodríguez

    Servicio Galego de Saúde (SERGAS)

    2 shared publications
  • Ana Barcia de la Iglesia

    Group of Genetics and Developmental Biology of Renal Disease, Laboratory of Nephrology, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital (CHUS), Santiago de Compostela, Spain

    1 shared publication
  • Beatriz Fernandez-Marta

    Department of Ophthalmology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain

    1 shared publication

Latest Publications

  • Open Access

    A comparative proteomic, transcriptomic and glycomic analysis of extracellular vesicle isolation techniques highlights ExoGAG efficiency for a more complete identification of breast milk molecular signaling pathways

    by María Pereira-Hernández, Rosaura Picáns-Leis, María E. Vázquez-Mosquera, Nerea Lago-Baameiro, Pedro Fortes-González, Laura López-Valverde, Ana Barcia de la Iglesia, Laura Núñez-González, Susana B. Bravo, María Pardo, et al.

    Human milk (HM) is the first form of communication between mothers and newborns and it is implicated in the infant growth and protection. We recently showed a functional characterization of HM, unmasking the molecular mechanisms related to EVs signaling and its functional role in prematurity. In that study, we identified the need to establish and optimize a standard isolation protocol for human milk extracellular vesicles (mEVs). Four mEVs isolation methods were compared: ultracentrifugation (UC), size exclusion chromatography (SEC), immunoprecipitation with tetraspanin CD9 (IP_CD9) and ExoGAG. Three pools of human milk (each composed of samples from ten donor mothers) were used and isolation of mEVs was performed starting from the same volume for each method. The proteomic, transcriptomic and glycomic composition of the extracellular vesicles obtained after isolation was then analyzed for each method. The sensitivity, specificity and quality of the results were also determined. A comparative analysis of results common across all isolation methods was performed to identify potential signaling pathways associated with mEVs. ExoGAG and UC proved to be the most efficient of the four techniques compared for mEVs isolation. However, ExoGAG compared to UC provided a higher concentration of total and vesicle-related proteins and peptides and a higher glycoprotein count keeping all the glycan subgroups. Despite ExoGAG and UC show similar vesicle profiles in terms of size, concentration, tetraspanin subpopulations and EVs markers, ExoGAG was the most efficient technique in terms of accuracy, consistency and reproducibility for omics studies. Furthermore, results allowed us to identify that mEVs components are involved in the signaling pathways of infant biological development, immune system maturation and protein metabolism. This study establishes UC and ExoGAG as reliable methods for mEVs isolation and describes its protocol, being ExoGAG the most efficient. Also, the omics analysis show that biomolecules conforming those mEVs are linked to the defense system against external agents (specific role in the immune system pathway) and in the correct establishment of the neural structure (developmental pathway), while providing all the nutritional requirements for the correct growth of the newborn (metabolic pathway).


  • Noncoding RNAs in intraocular tumor patients

    by Daniel Fernandez-Diaz, Beatriz Fernandez-Marta, Nerea Lago-Baameiro, Paula Silva-Rodríguez, Laura Paniagua, María José Blanco-Teijeiro, María Pardo, Antonio Piñeiro, Manuel F. Bande

  • PARK7/DJ-1 inhibition decreases invasion and proliferation of uveal melanoma cells

    by Nerea Lago-Baameiro, Maria Santiago-Varela, Tamara Camino, Paula Silva-Rodríguez, Manuel Bande, Maria Jose Blanco-Teijeiro, Maria Pardo, Antonio Piñeiro

    Introduction: PARK7/DJ-1 is an oncogene that is associated with tumorigenesis in many cancers. Recent studies have demonstrated the importance of DJ-1 in the origin and development of uveal melanoma (UM). We present an analysis of the role of the DJ-1 protein in UM cells, especially in its effect on proliferation and migration. Methods: UM cells from a primary tumor, Mel 270, and its liver metastasis, OMM2.5, were transfected with lentiviral-delivered shRNA against PARK7/DJ-1. Evaluation of cell migration and proliferation was performed using the xCELLigence real-time cell analyzer (RTCA). The effect of DJ-1 inhibition on the PTEN-Akt signaling pathway was also studied by immunoblotting. Results: The silencing of PARK7/DJ-1 oncoprotein expression produced a significant decrease of phosphorylated Akt (S473) in Mel270 and in metastatic OMM2.5 UM cells with no alteration on tumor suppressor PTEN expression. The diminution of PARK7/DJ-1 expression significantly inhibited real-time proliferation and invasion of Mel270 and OMM2.5 and the invasion potential of the metastatic cells. Conclusion: DJ-1 appears to play a key role on the PTEN/Akt pathway in UM. DJ-1 inhibition appears to have a negative effect on proliferation and invasion of UM cells. This suggests DJ-1 as a potential therapeutic target in UM.